Ye; Yingda
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ye; Yingda.The latest application filed is for "heterocyclic compounds as immunomodulators".
- Ye; Yingda - Wilmington DE
| Patent | Date |
|---|---|
| Heterocyclic Compounds As Immunomodulators App 20220194931 - Wu; Liangxing ; et al. | 2022-06-23 |
| Tricyclic Heterocyclic Compounds As Sting Activators App 20220073509 - Wu; Liangxing ; et al. | 2022-03-10 |
| Tricyclic Heteroaryl Compounds As Sting Activators App 20210332067 - Wu; Liangxing ; et al. | 2021-10-28 |
| Pyrrolopyrimidine derivatives as TAM inhibitors Grant 11,136,326 - Li , et al. October 5, 2 | 2021-10-05 |
| Tricyclic heteroaryl compounds as STING activators Grant 11,008,344 - Wu , et al. May 18, 2 | 2021-05-18 |
| Heterocyclic Compounds As Immunomodulators App 20210107900 - Wu; Liangxing ; et al. | 2021-04-15 |
| Bicyclic Amines As Cdk2 Inhibitors App 20210107901 - Ye; Yingda ; et al. | 2021-04-15 |
| Tricyclic heterocyclic compounds as sting activators Grant 10,947,227 - Wu , et al. March 16, 2 | 2021-03-16 |
| Immunomodulator Compounds And Methods Of Use App 20200397893 - Liu; Phillip C. ; et al. | 2020-12-24 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20200306256 - Lu; Liang ; et al. | 2020-10-01 |
| Heterocyclic compounds and uses thereof Grant 10,723,705 - Pan , et al. | 2020-07-28 |
| Pyrrolopyrimidine Derivatives As Tam Inhibitors App 20200181151 - Li; Yun-Long ; et al. | 2020-06-11 |
| Tricyclic Heteraryl Compounds As Sting Activators App 20200040009 - Wu; Liangxing ; et al. | 2020-02-06 |
| Pyrrolopyrimidine derivatives as TAM inhibitors Grant 10,519,163 - Li , et al. Dec | 2019-12-31 |
| Tricyclic Heterocyclic Compounds As Sting Activators App 20190359608 - Wu; Liangxing ; et al. | 2019-11-28 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20190269693 - Lu; Liang ; et al. | 2019-09-05 |
| Heterocyclic Compounds As Immunomodulators App 20190225601 - Wu; Liangxing ; et al. | 2019-07-25 |
| Pyrrolopyrimidine Derivatives As Tam Inhibitors App 20190031663 - Li; Yun-Long ; et al. | 2019-01-31 |
| Heterocyclic Compounds And Uses Thereof App 20180244627 - Pan; Jun ; et al. | 2018-08-30 |
| Pyrrolopyrimidine derivatives as TAM inhibitors Grant 10,053,465 - Li , et al. August 21, 2 | 2018-08-21 |
| Heterocyclic Compounds As Immunomodulators App 20180179197 - Wu; Liangxing ; et al. | 2018-06-28 |
| Immunomodulator Compounds And Methods Of Use App 20180177870 - Liu; Phillip C. ; et al. | 2018-06-28 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20170290839 - Lu; Liang ; et al. | 2017-10-12 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 9,708,318 - Lu , et al. July 18, 2 | 2017-07-18 |
| Pyrrolopyrimidine Derivatives As Tam Inhibitors App 20170057965 - Li; Yun-Long ; et al. | 2017-03-02 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20160244449 - Lu; Liang ; et al. | 2016-08-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 